Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/9554
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorINCA-
dc.date.accessioned2022-07-27T19:26:21Z-
dc.date.available2022-07-27T19:26:21Z-
dc.date.issued2011-09-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/9554-
dc.subjectTratamento Farmacológicopt_BR
dc.subjectDrug Therapypt_BR
dc.subjectQuimioterapiapt_BR
dc.titleQuimioterapia do HC I está maior e mais humanizadapt_BR
dc.title.alternativeInforme INCA 292pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 292

Files in This Item:
File Description SizeFormat 
Informe INCA 292-10.pdf62.53 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.